HIK Hikma Pharmaceuticals Plc LSE · United Kingdom

Hikma Pharmaceuticals Plc (HIK) news

Hikma Pharmaceuticals Plc is a public biotech or pharmaceutical company listed on LSE under the ticker HIK, recorded under United Kingdom. The directory classifies it as Pharmaceuticals: Generic. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Hikma Pharmaceuticals Plc news

We have not published a story on Hikma Pharmaceuticals Plc yet. When there is news, it will appear here.

Questions about Hikma Pharmaceuticals Plc

What is the ticker symbol of Hikma Pharmaceuticals Plc?

Hikma Pharmaceuticals Plc trades under the ticker HIK on LSE.

Where is Hikma Pharmaceuticals Plc listed?

Hikma Pharmaceuticals Plc is listed on LSE. Our directory also records these other listings: BMV:HIK/N; GETTEX:H5P; LSX:A0HG69; NASDAQDUBAI:HIK; OTC:HKMPF; OTC:HKMPY.

Which country or territory is Hikma Pharmaceuticals Plc listed under?

Our directory records Hikma Pharmaceuticals Plc under United Kingdom.

What does Hikma Pharmaceuticals Plc do?

Our directory classifies Hikma Pharmaceuticals Plc as: Pharmaceuticals: Generic. This is a directory classification, not a description of the pipeline.

What is the ISIN of Hikma Pharmaceuticals Plc?

The ISIN recorded for Hikma Pharmaceuticals Plc is GB00B0LCW083.

Does aibio.space cover Hikma Pharmaceuticals Plc?

aibio.space lists Hikma Pharmaceuticals Plc among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Hikma Pharmaceuticals Plc?

Companies in our directory listed in the same country and business area as Hikma Pharmaceuticals Plc: AstraZeneca, Genflow Biosciences Plc, Adaptimmune Therapeutics, HemoGenyx Pharmaceuticals Plc, Shield Therapeutics Plc, Futura Medical.

Investor discussion: Hikma Pharmaceuticals Plc

Members talk about Hikma Pharmaceuticals Plc (HIK). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open LSE:HIK on TradingView.

Listing details

Company: Hikma Pharmaceuticals Plc
Ticker: HIK
Listing: LSE
Country or territory: United Kingdom
Business scope: Pharmaceuticals: Generic
ISIN: GB00B0LCW083
Other listed symbols: BMV:HIK/N; GETTEX:H5P; LSX:A0HG69; NASDAQDUBAI:HIK; OTC:HKMPF; OTC:HKMPY
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction